latest news releases from the newsroom
Thinkbig Launches Strategic Advertising Campaign for Action Sports Leader - Rusty
ALISO VIEJO, Calif., Jan. 5, 2004 (PRIMEZONE) -- Thinkbig, an award-winning Orange County-based advertising agency, today announced the launch of a strategic campaign for surfboard and apparel maker, Rusty. The advertising campaign is designed to differentiate Rusty in the mind of its consumers, by reconnecting the brand to its original core product - the surfboard.
Zavesca(r) Capsules Available for Prescription in the U.S.
ALLSCHWIL and BASEL, Switzerland, Jan. 5, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced the availability of Zavesca(r) (miglustat) capsules in the United States. Zavesca(r) is the first oral treatment option for type I Gaucher disease and is also already approved and available in the European Union.
Schiffrin Barroway Topaz & Kessler, LLP
The Law Firm of Schiffrin & Barroway, LLP Announces that Excelsior Mutual Fund Investors have Twenty Days Remaining to File Lead Plaintiff Motion -- UMCAX, UMLCX, UMEIX, UMBTX
BALA CYNWYD, Pa., Jan. 5, 2004 (PRIMEZONE) -- Excelsior Mutual Fund investors have twenty (20) days to move for lead plaintiff in a securities fraud class action recently brought against The Charles Schwab Corporation (NYSE:SCH), Charles Schwab & Co., Inc., U.S. Trust Corporation, and the Excelsior Mutual Funds. If you purchased any of the Excelsior Funds listed below between November 23, 1998 and November 14, 2003, inclusive (the "Class Period") and you wish to be a lead plaintiff in the case, you must move to serve as lead plaintiff by filing a motion in the United States District Court for the Northern District of California by January 20, 2003.
GlaxoSmithKline Licenses SkyePharma Formulation Technology for Respiratory Drugs
LONDON, Jan. 5, 2004 (PRIMEZONE) -- SkyePharma PLC (LSE:SKP) (Nasdaq:SKYE) today announced a licence agreement with GlaxoSmithKline (LSE:GSK) (NYSE:GSK) to provide access to one of SkyePharma's proprietary formulation technologies for application to the delivery of respiratory drugs either by breath-actuated dry-powder inhaler or by metered-dose aerosol inhaler. The agreement was signed at the end of 2003 and GSK made an initial payment to SkyePharma on signature. If the patented formulation technology is subsequently incorporated into current or future products by GSK, SkyePharma will also be entitled to an additional payment for each such product and a royalty on eventual sales.
NeoMedia Technologies, Inc.
Virgin Entertainment, Virgin Megastore Online and Virgin Megastore are Charged with Patent Infringement by NeoMedia Technologies, Inc.
FT. MYERS, Fla., Jan. 5, 2004 (PRIMEZONE) -- NeoMedia Technologies, Inc. (OTCBB:NEOM), a developer and international marketer of software and patented technologies which link products, print, and physical objects directly to targeted online data, said today that it has filed a patent infringement lawsuit against Virgin(r) Entertainment Group, Inc., Virgin Megastore Online and Virgin Megastore (Virgin).
Strategy Partners, LLC
ZENITH TECHNOLOGY Acquires ADSOUTH
IRVINE, Calif., Jan. 5, 2004 (PRIMEZONE) -- Today, ZENITH TECHNOLOGY, INC. (OTCBB:ZNTH) has acquired 100% of ADSOUTH, INC., a Boca Raton based media placement and creative marketing firm with 4th quarter 2003 revenues in excess of $650,000 and pre-tax net profits above $95,000.